Phase Forward`s Russell J. Campanello Honored withSTEVIE® Award for Human Resources Executive of the Year

* Reuters is not responsible for the content in this press release.

Wed Jun 24, 2009 10:43am EDT

WALTHAM, Mass.--(Business Wire)--
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions
for clinical trials and drug safety, today announced that Russell J. Campanello,
the company`s senior vice president of human resources and administration, has
been honored with a Stevie® Award for the Human Resources Executive of the Year.
The award was presented at The 7th Annual American Business AwardsSM gala this
past Monday night at the Marriott Marquis Hotel in New York City. 

Stevie Awards were presented in over 40 categories this year including Best
Overall Company of the Year, Executive of the Year and Corporate Social
Responsibility Program of the Year. More than 2,600 entries from companies of
all sizes and in virtually every industry were submitted for consideration. In
addition, more than 200 executives across the country participated in the
judging process to determine the Finalists and Stevie Award winners. 

"It`s gratifying to be presented with this award and recognized among the many
talented executives in the human resources profession," said Campanello. "I`m
grateful to the organizers of the Stevie Awards and to the dedicated employees
of Phase Forward, whose hard work and commitment I find inspiring and
energizing." 

Campanello was recognized for his efforts in creating an environment that
maximizes the contributions of Phase Forward`s talented employees. He has
focused in particular on fostering an atmosphere of consistent and open
communication, soliciting employee feedback through multiple channels on a wide
variety of issues, and responding to the feedback with both formal programs and
less formal interpersonal communication. A Boston Globe article about companies`
efforts to communicate with their employees regarding the economic downturn
cited Campanello`s emphasis on "honesty and transparency." 

For more information about The American Business Awards and to view the list of
this year`s Finalists and Stevie Award winners, click here. 

About The Stevie Awards

Stevie Awards are conferred in four programs: The American Business Awards, The
International Business Awards, The Stevie Awards for Women in Business, and the
Stevie Awards for Sales & Customer Service. Honoring companies of all types and
sizes and the people behind them, the Stevies recognize outstanding performances
in the workplace worldwide. Learn more about The Stevie Awards at
www.stevieawards.com. 

Supporting sponsors of The 2009 American Business Awards include High
Performance Technologies Inc., John Hancock, LifeLock, RCN Corporation, Softpro,
and Ultimate Software. Media sponsor is the Business TalkRadio Network.
Localization partner of the 2009 Stevie Awards is Lionbridge. 

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for
clinical trials and drug safety. Phase Forward`s products and services have been
utilized in over 10,000 clinical trials involving more than 1,000,000 clinical
trial study participants at over 290 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer
Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline,
Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk,
PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis,
Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about Phase
Forward is available at www.phaseforward.com. 

Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5994034&lang=en





Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
CHEN PR, Inc.
Meghan Locke, 781-672-3147
mlocke@chenpr.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.